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 Abstract 
Identifying the return of fertility with cervical mucus observations is challenging during the 
postpartum period. Use of urinary measurements of estrogen and progesterone can assist in 
understanding the return to fertility during this period. The purposes of this study were to describe the 
postpartum return of fertility by an analysis of total estrogen (TE) and pregnanediol glucuronide (PDG) 
profiles and to correlate these profiles with cervical mucus observations. Twenty-six participants 
collected urine samples during the postpartum period and recorded mucus scores. TE and PDG 
hormones were analyzed and compared with mucus scores. During amenorrhea, mucus reflected TE 
changes in only 35 percent of women; after amenorrhea, typical mucus patterns were seen in 33 
percent of cycles. We concluded that postpartum mucus and hormone profiles are significantly 
dissociated but that monitoring urinary hormones may assist in identifying the return of fertility. We 
also identified different hormonal patterns in the return to fertility. 
The postpartum period is a challenging time for identifying the return of fertility. The purposes 
of this study were to describe the hormonal patterns during the return of fertility and to correlate these 
patterns with cervical mucus observations. Twenty-six postpartum women collected urine samples and 
recorded mucus scores. Urinary estrogen and progesterone hormones were analyzed and compared 
with mucus scores. Before the return of menses, mucus reflected hormonal changes in only 35 percent 
women and after first menses in 33 percent of cycles. We found that hormone profiles do not correlate 
well with mucus observations during the postpartum return of fertility. 
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Although natural family planning (NFP) is recommended as a healthy option for avoiding 
pregnancy among postpartum, breastfeeding women, use of NFP postpartum can be difficult with lower 
rates of effectiveness (Labbok, Nichols-Johnson, and Valdes-Anderson 2006; Academy Breastfeeding 
Medicine 2006). One of the major reasons that NFP can be difficult for use during the postpartum period 
is because of the great variability and the unpredictability of the return to fertility (Li and Qiu 2007). 
Another reason is that natural indicators of fertility, such as cervical mucus observations and basal body 
temperature are often difficult to interpret during the postpartum transition to fertility (Tommaselli et 
al. 2000). Finally, some researchers have found a dissociation between cervical mucus observations and 
hormonal indicators of ovarian activity (Brown, Harrison, and Smith 1985; Blackwell et al. 2016) and a 
dissociation between follicular growth and hormone activity (Velasquez et al. 2006a). 
The time from the birth of a baby until the resumption of regular ovulatory menstrual cycles is 
known as the postpartum/breastfeeding transition to fertility. In general, the postpartum transition 
includes (1) the immediate postpartum anovulatory amenorrhea with ovarian quiescence, (2) a phase of 
ovarian activity (follicular development), (3) possible ovulation prior to first menses, (4) the first menses 
and irregular menstrual cycle phase (with long follicular phases and short luteal phases that may last 
three to six months after the resumption of menses), and, finally, (5) the resumption of regular 
menstrual cycles. 
Physiology of the Breastfeeding Transition 
The return of fertility is summarized in detail from an endocrine point of view by McNeilly 
(2001), who was involved in many studies evaluating hormonal changes with lactation. Initially, high 
levels of estrogen and progesterone from the placenta inhibit ovulation during pregnancy and the 
immediate postpartum period. In addition, these high levels of hormones from the placenta suppress 
the release of follicle-stimulating hormone (FSH) and the development of follicles, so that minimal 
follicles are present at the time of delivery. During pregnancy, luteinizing hormone (LH) synthesis is 
chronically inhibited, and LH content in the pituitary is minimal. For women who breastfeed, suckling 
continues to inhibit the normal pulsatility of gonadotropin-releasing hormone (GnRH) and consequently 
LH pulsatility as well. This inhibition is correlated with prolactin levels, but the precise action of prolactin 
is unclear since some women do not always have increased prolactin with suckling, and there is 
variability in the actual levels of prolactin when ovulation resumes, suggesting that different women 
have different sensitivity to prolactin concentrations. Suckling enhances the feedback mechanism of 
estrogen on the pituitary, so that even small amounts of estrogen from immature follicles have a strong 
effect. These small amounts of estrogen, which in a normally menstruating woman would not affect the 
pituitary, lead to suppression (negative feedback) of FSH in breastfeeding women. In addition, suckling 
dampens estrogen’s positive feedback which usually stimulates the GnRH/LH pulse generator. The 
dampened stimulation leads to GnRH/LH pulses that are erratic and which are not sufficient to lead to 
ovulation (GnRH/LH requires a regular pulse interval of sixty to ninety minutes to drive normal follicle 
secretion). Since suckling increases the sensitivity of the pituitary to small amounts of estrogen, there 
are cycles of follicle growth and regression which do not lead to ovulation for several months (McNeilly 
2001). It is only later when suckling is decreased and other forms of nutrition are introduced (often after 
six months when most guidelines suggest solids should be introduced) that ovulation then resumes. 
Interestingly, a group of researchers recently found that developing follicles were larger during 
the amenorrhea phase than during the follicular phase in the first menstrual cycle postpartum 
(Velasquez et al. 2006a), and in a separate study, they reported that there were different isoforms of 
FSH present during amenorrhea compared to the first menstrual cycle and that the isoform present 
during amenorrhea was less potent/bioactive (Velasquez 2006b). In the first study, both the number and 
diameter of the follicles were significantly greater during breastfeeding amenorrhea compared to the 
early and mid-follicular phases of regular menstrual cycles. However, these larger follicles had low levels 
of inhibin B (produced in early stages of follicular development) and overall absence of inhibin A 
(secreted by more differentiated and luteinized cells). These authors concluded that during lactational 
amenorrhea, follicular response to FSH is altered due to the reduced biopotency of FSH isoforms leading 
to follicles that are larger but immature, producing minimal amounts of estrogen. Interpreting 
McNeilly’s model and Velasquez’s findings together, it is possible that suckling and prolactin levels affect 
the estrogen-FSH feedback loop by favoring less potent FSH isoforms. Eventually with less suckling, the 
more bioactive FSH becomes upregulated instead, leading to the development of more mature (albeit 
smaller) follicles. In these more mature follicles, sufficient amounts of estrogen can be produced to 
trigger the GnRH/LH pulse generator that becomes more regular (less erratic), thus leading to ovulation. 
Efficacy of NFP during the Breastfeeding Transition 
There are few studies that have investigated the efficacy of NFP methods during the 
breastfeeding transition. Over thirty years ago, an Australian study followed fifty-five postpartum, 
breastfeeding women for a mean of 7.8 months to discern patterns of returning fertility by comparing 
both mucus changes and urinary hormone measurements of TE and PDG (Brown, Harrisson, and Smith 
1985). They discovered that mucus symptoms overestimated urinary hormone changes in 21 percent of 
women, underestimated hormone changes in 21 percent of women, with the remaining 58 percent of 
women with mucus score accurately reflecting their ovarian activity determined by urinary hormones. In 
their small study, fourteen of the fifty-five participants (25 percent) had an unintended 
pregnancy. Hatherley (1985) investigated the efficacy of NFP among 251 postpartum women who were 
using NFP methods to avoid pregnancy and found, after one full year postpartum, there were thirty-four 
(16 percent) unintended pregnancies among the breastfeeding group and two (5 percent) among 
women who did not breastfeed at all. Hatherley concluded that the variability of the menstrual cycles 
and the dissociation with the hormonal fluctuations during the postpartum period were not conducive 
to the use of NFP. Other researchers found that unintended pregnancy rates were higher among 
breastfeeding women following the ovulation method when back in cycles compared to 
nonbreastfeeding women (Labbok et al. 1991). This may be because observing mucus signs while 
breastfeeding may lead to increased confusion in the interpretation of mucus. They concluded that 
special emphasis needs to be made among breastfeeding women using the ovulation method 
postpartum, including this increased potential for method failure while breastfeeding. With an 
experienced NFP instructor, many women can navigate this challenging time with more discerning 
attention to mucus, although this is not always the case and often increases required abstinence 
(Kennedy et al. 1995). 
Howard and Stanford (1999) investigated a subset of breastfeeding women who were using the 
Creighton Model ovulation method of NFP and discovered a net pregnancy rate of 24 percent and gross 
rate of 32 percent. They concluded that the higher pregnancy rate (compared to regularly cycling 
women using the Creighton Model) might be due to a higher rate of “achieving related behaviors” 
(having intercourse when mucus is identified as fertile) among the breastfeeding group of women. 
Although they did not comment on this, it is possible that some of the method failure could be related 
to mucus not reflecting fertility status. In another study, researchers from Georgetown applied the rules 
of two simpler methods of NFP retrospectively on a data set of breastfeeding women and found that 
they may be effective, but this requires a more robust follow-up trial to evaluate effectiveness 
prospectively (Aravelo et al. 2003). 
A more recent NFP efficacy study during the postpartum period (which included both 
breastfeeding and nonbreastfeeding women), using an electronic hormonal fertility monitor that 
measured daily urinary levels of E1G and a threshold level of LH found a typical use pregnancy rate of 
eight per 100 women over twelve months (Bouchard, Schneider, and Fehring 2013). Ahead of their 
time, Brown, Harrison, and Smith’s (1985) study remarkably suggested that simple methods for 
measuring urinary hormones (estrogen and PDG) are required to assist women whose mucus 
observations do not reflect underlying hormone changes. 
Variability during the Breastfeeding Transition 
Understanding the dynamics and complexity of the breastfeeding transition will help with 
designing protocols for use with NFP methods since the breastfeeding transition is complex and 
extremely variable (Fehring, Schneider, and Barron 2005). For example, studies on the postpartum 
transition to fertility in breastfeeding women found a mean range of the first ovulation from 193 to 322 
days (6.3–10.6 months, and actual range of 24–750 days) and a mean range of the first menses from 179 
to 298 days (5.9–9.8 months, actual range 35–698 days; Hatherley 1985; Lewis et al. 1991; Li and Qui 
2007). About 33 percent of breastfeeding women will have their first ovulation before their first menses 
if it occurs in the first three months postpartum, but this figure goes up to 87 percent if first menses 
occurs after the first twelve months (ovulation was based on salivary progesterone rise or urinary 
pregnanediol rise above the established threshold for ovulation; Lewis et al. 1991). In the Lewis et al. 
(1991) study, they found that only 20 percent had ovulated and more than 25 percent had menstruated 
by six months postpartum, but by twelve months 64 percent had ovulated and 70 percent had 
menstruated. Based on several studies, it has also been demonstrated that after the first ovulation, the 
luteal phases are often short (i.e., less than six days) with a gradual lengthening over the course of the 
transition to regular cycles (Lewis et al. 1991; Zinaman and Stevenson 1991; Diaz et al. 1992; Li and Qui 
2007). Mothers who ovulate early during full breastfeeding will tend to do the same for future babies. 
Research has shown that mothers tend to have a return to fertility at about the same time postpartum 
from one breastfeeding experience to the other when breastfeeding intensity is similar (Ecochard et al. 
1988). 
In 1995, a study was published which involved a sample of seventy-one postpartum, 
breastfeeding women who were users of the symptothermal method (STM) of NFP from Sydney, 
Montreal, and Birmingham (England) (Kennedy et al. 1995). The purpose of this study was to correlate 
the estimated days of fertility (i.e., required abstinence for avoiding pregnancy) with daily urinary 
measures of TE and PDG to estimate the day of ovulation and the actual fertile days during the 
postpartum transition to fertility. The result was that the STM overestimated the actual days of fertility 
by 50 percent or more. However, the hormonal data from this study have not been extensively analyzed 
in describing the hormonal return to fertility. 
Another study evaluating urinary PDG and the return of fertility postpartum addressed 
breastfeeding patterns in relation to return of fertility (Taylor et al. 2003). This study (N = 144) found 
that more “ecological breastfeeding” or breastfeeding on demand with frequent suckling was associated 
with a median postpartum delay of fifty-five weeks until the first PDG rise. 
The purpose of the current study was to identify the return of fertility postpartum with a 
descriptive analysis of TE and PDG profiles as measured in the urine as well as to correlate these 
hormonal profiles to cervical mucus observations. The results will serve to assist in the development of 
postpartum transition protocols for NFP. 
Method 
Participants 
Of the seventy-one participants in the original study (Kennedy et al. 1995), only twenty-six had 
demographics available for the current study (Montreal data). The mother’s age, parity, gravity, and 
breastfeeding characteristics were collected. As described in detail in the 1995 study, data were 
collected from 1986 to 1990 and included daily records regarding breastfeeding, STM signs, coital 
frequency (see partial STM chart in Figure 1, excluding temperature and cervix changes, which were not 
analyzed in this study), and a daily sample of urine. Data collection began in the seventh-week 
postpartum. The protocol that women followed is included in Appendix A, Brown Ovarian Monitor 
Guidelines. 
 
Figure 1. Representative symptoms chart from participant 111, from April to June 1986 (in French). Mucus coding 
is represented by a green color for “dry” mucus (Colombo score of 1, Marquette “Low” mucus), a yellow color for 
“moist, damp” mucus (Colombo score of 2 or 3, Marquette “High” mucus), and a blue color for “clear, slippery, 
stretchy” (Colombo score of 4, Marquette “Peak” mucus). Other signs, used in the symptothermal method, 
including temperature and cervix changes, are not shown here because they have not been analyzed in this study. 
(French terms: saignements = bleeding, glaire = mucus, douleurs abdominales = abdominal pain, pertes roses = 
spotting, sensibilité aux seins = breast tenderness, symptômes divers = miscellaneous symptoms, rapports sexuels = 
intercourse, infections = infections, dérangements = disturbances, jours après accou. = days after parturition, jours 
du calendrier = calendar days.) 
 
Mucus Observations 
As shown in Figure 1, a variety of mucus characteristics can be observed readily by women and 
are generally classified according to sensation and appearance. Sensation descriptions include dry, 
damp, moist, sticky, wet, and slippery. Appearance descriptions include thick, white, yellowish, stretchy, 
and clear. In order to simplify these descriptions, one of the researchers gave a three-tiered code to the 
mucus based on these descriptions: (1) a green color for “dry” mucus, (2) a yellow color for “moist, 
damp, sticky” mucus, and (3) a blue color for “clear, wet, slippery, stretchy” mucus. Of interest, this 
coding is analogous to other groups’ simplified mucus coding schemes including Colombo’s score of 1 
for dry mucus (“green”), a score of 2–3 for damp/thick/white/yellow/sticky mucus (“yellow”), and a 
score of 4 for slippery/transparent/stretchy mucus (“blue”; Bigelow et al. 2004). The Marquette 
Method’s coding of “Low,” “High,” and “Peak” mucus also corresponds to the three color levels used in 
these charts (Bouchard et al. 2013). 
Urine Collection 
Daily timed urine samples were collected until two ovulations were confirmed by the laboratory. 
The women collected urine daily using the following procedure. The women collected urine passed for a 
period of at least three hours, in the morning or at a convenient time of the day. The minimum 
collection period of three hours was specified to reduce error caused by unpassed urine. The urine 
sample was collected into a container, the number of hours of collection and the volume was calculated, 
and a small aliquot transferred into a tube that was labeled with the participant number, center 
number, date, hours, and volume and kept frozen until the batch was sent in dry ice to the laboratory in 
Melbourne by air. The samples were thawed, diluted to 100 ml/h, and analyzed by homogeneous 
enzyme immunoassay (Rubenstein, Schneider, and Ullman 1972). 
TE Assays 
The estrogen assay used was a “total” estrogen spectrophotofluorometric method using purified 
extracts of acid hydrolyzed urine as described previously that measured the sum of estrone, estradiol, 
and estriol, using the Kober–Ittrich procedure (Brown et al. 1968). The sum (or “total” estrogens) 
excreted into the urine in twenty-four hours (the excretion rate) is important since it is directly related 
to the ovarian estradiol production rate (Brown 1957, 2011), whereas simple concentration (amount per 
volume) is not. The data from the total estrogen method were the most accurate available as the total 
estrogen method was of proven reliability and specificity (Brown 2011), had no urine blank or matrix 
effects, and had a coefficient of variation of 8 percent determined from quality controls included with 
each assay run. 
PDG Assay 
The PDG assay was carried out with the laboratory version of the homogeneous enzyme 
immunoassay used in the Ovarian Monitor system employing a specially designed rate colorimeter 
thermostated at 40°C with timer settings for the warm-up and enzyme reactions (Brown 1985). For the 
multiple assays in this study, a thermostated heating block was used which accommodates up to forty-
eight assay tubes; the timings were performed manually using a stop watch. In this way up to twenty 
PDG assays could be performed in rapid sequence since the time for the PDG assay is five minutes. The 
PDG assay utilizes the principle of homogeneous enzyme immunoassay (Rubenstein, Schneider, and 
Ullman 1972; Blackwell et al. 2003) in which an antibody to a ligand specifically inhibits the enzyme 
activity of a conjugate of the ligand chemically bound to the enzyme. It is important to appreciate that 
the assay has been designed to operate over a limited but clinically significant concentration range. The 
sensitivities of the assays using 10 µl of a time-diluted urine sample for PDG were set to include the 
most important ranges of values required to identify the thresholds of fertility and infertility during the 
human ovulatory cycle (Blackwell 2003; Brown 2011; Blackwell et al. 2011). The homogeneous enzyme 
immunoassay has an upper ceiling reached when the entire antibody is neutralized by the hormone 
metabolite in the urine and a lower limit largely determined by nonspecific components of the urine. 
This latter effect is termed the urine bias; it is more limiting for the estrogen tubes than for the PDG 
tubes because of the larger urine volumes and longer incubation times used. For quantitative results, all 
values approaching the upper ceiling were repeated using less urine in the assay tubes. Quality control 
urine samples were added to each run, and the coefficient of variation was 5–10 percent. 
TE Thresholds and Ovarian Activity 
Both TE and PDG are measured as excretion rates, expressed in µg/24 h for TE and in µmol/24 h 
for PDG. For the TE excretion rates, values between 0 and 10 µg/24 h were reflective of minimal ovarian 
activity, values between 10 and 20 µg/24 h were reflective of follicular development, and values >20 
µg/24 h were reflective of peak changes and impending ovulation (based on previous experience using 
the assay used in Brown, Harrison, and Smith 1985). 
PDG Thresholds and the Retrospective Definition of Ovulation with PDG Levels 
Based on previous studies using the same assays (Brown 2011), PDG excretion rates have been 
defined as (see Table 1): (1) the start of the postovulatory infertile period (7 µmol/24 h), (2) a luteinized 
unruptured follicle (7 to <9 µmol/24 h), (3) biochemical evidence that ovulation has occurred (≥9 
µmol/24 h), (4) a deficient luteal phase (9–13.5 µmol/24 h), and (5) a fertile cycle (>13.5 μmol/24 h 
within six days of a TE peak and a luteal phase of eleven to seventeen days). 
Table 1. PDG Thresholds and Definitions. 
PDG Threshold Physiologic Definition 
7 mmol/24 h Threshold for the onset of the postovulatory infertile phase 
>7 but <9 mmol/24 h Luteinized unruptured follicle 
_9 mmol/24 h Biochemical proof of ovulation 
_9 but <13.5 mmol/24 h Deficient luteal phase 
>13.5 mmol/24 h Fertile cycle if this followed within six days of a TE peak and the luteal 
phase is eleven to seventeen days long 
Note: PDG¼ pregnanediol glucuronide; TE¼ total estrogen 
 
Statistical Analyses 
Demographics were analyzed using means and standard deviations. Time to biochemically 
proven ovulation (in months) was calculated from the time of the baby’s birth until urinary PDG levels 
were at least 9 µmol/24 h, which is a biochemical proof of ovulation based on previous analyses (Brown 
2011). First menses was determined by identifying a bleeding pattern that spanned three days or more 
and included at least one day of moderate or heavy bleeding. Time to menses and time to ovulation 
were also compared to the time of weaning from full breastfeeding. Time to fertility was based on the 
first ovulation that met the criteria for a fertile cycle (PDG > 13.5). 
Hormone values for individual women were graphically displayed using R software (Version 
0.16) (Ihaka and Gentleman 1996) and interpreted qualitatively. Patterns of ovarian activity were 
classified based on presumed follicular activity inferred from TE changes, and ovulation based on PDG 
changes. These patterns were then organized into broad categories for the sake of describing the 
postpartum transition. 
Daily mucus ratings of “green,” “yellow,” and “blue” were correlated with the daily TE levels. On 
any given day, a mucus rating was identified as accurately reflecting the TE level if mucus was rated 
“green” when TE levels were <10 µg/24 h, if mucus was rated “yellow” when TE levels were 10–20 µg/24 
h, and if mucus was rated “blue” when TE levels were >20 µg/24 h. In addition, a mucus rating was 
identified as either underestimating the TE level (if mucus was rated “green” when the TE levels were 
>10 µg/24 h, or was rated “yellow” when TE levels were >20 µg/24 h) or overestimating the TE level (if 
mucus was rated “yellow” or “blue” when TE levels were <10 µg/24 h, or if mucus was rated “blue” 
when TE levels were between 10 and 20 µg/24 h). These levels were based on field experience using the 
monitor developed based on the methods in Brown, Harrison, and Smith (1985). 
Mucus ratings were also compared to progesterone activity and were evaluated for each cycle 
after the first ovulation. Since rising progesterone levels are believed to be responsible for the drying 
effect on the mucus after ovulation, each cycle was identified as having a typical mucus pattern if mucus 
changed to a basic infertile pattern (not necessarily dry mucus) after the progesterone rise. And 
conversely, cycles were identified as not reflecting the underlying progesterone changes if mucus did 
not return to the basic infertile pattern. Also, cycles were identified as not reflecting the underlying 
progesterone changes when the mucus pattern showed an apparent drying effect when the 
progesterone rise had not yet started. The progesterone changes were identified from the urinary PDG 
excretion rates that closely reflect the serum progesterone changes (Munro et al. 1991). The PDG values 
on the day following the apparent mucus peak days (a change from blue to yellow or green) were 
assessed for each patch of mucus. 
Results 
Demographics 
The mean age of women in our sample (at the time of their baby’s birth) was 29 (±3.4, range 23–
35). The average number of living children (including the one just delivered) was 2.3 (±1.3, range: 1–5). 
Time to Menses and Time to Ovulation (Table 2) 
Table 2. Average Time to Menses and Ovulation in Relation to Breastfeeding Status. 
 Overall Return of Menses 
and Ovulation during 
Full Breastfeeding 
Return of Menses 
and Ovulation during 
Partial Breastfeeding 
Return of Menses 
and Ovulation 
after 
Full Weaning 
Time to 
menses 
7.4 months (+3.0, 
range: 1.3–11.7 
months; N ¼ 24) 
4.1 months (+2.2, 
range: 1.3–6.0 
months; N ¼ 5) 
9.8 months (+2.7, 
range: 4.2–14.4 
months; N ¼ 12) 
6.4 months (+3.0, 
range: 3.1–10.5 
months; N ¼ 5) 
Time to 
ovulation 
8.4 months (+3.1, 
range: 3.3–14.3 
months; N ¼ 22) 
5.6 months (+1.7, 
range: 3.0–7.0 
months; N ¼ 5) 
9.0 months (+2.2, 
range: 4.4–11.7 
months; N ¼ 12) 
7.9 months (+3.5, 
range: 3.8–12.3 
months; N ¼ 5) 
 
Time to first menses could be calculated for twenty-four women and was on average 7.4 months 
(±3.0, range: 1.3–11.7 months). Time to first ovulation (biochemical proof of ovulation: PDG ≥9 µmol/24 
h) could be calculated for twenty-two women and was on average 8.4 months (±3.1, range: 3.3–14.4 
months). 
The time of full breastfeeding was an average of 4.9 months (±1.4, range: 2.8–8.7 months), and 
the time to full weaning was an average of 16.1 months (±11.9, range: 2.4–44.7). Thus, the interval 
between full breastfeeding and complete wean was on average another 11.1 months ± 10.9, and one 
woman breastfed up to 44.7 months. Time from the end of full breastfeeding to menses was 2.4 months 
(±3.2, range: −5.2 to 6.7 months) and from the end of full breastfeeding to ovulation was on 3.3 months 
(±3.3, range: −1.6 to 9.1 months). 
Time from first menses to ovulation was on average 1.16 months (±1.5, range: −0.3 to 4.8 
months). In nine women (41 percent), ovulation occurred before menses, and in thirteen women (59 
percent) ovulation occurred after menses. In the nine women who ovulated before menses, ovulation 
occurred on average at 7.9 months (±2.45, range: 4.2–11.6 months), and had a luteal phase of three to 
eight days which would be considered too short for fertility. Of these nine women, seven of them (77 
percent) had ended full breastfeeding (0.25–5.0 months prior). Of the thirteen women who had 
ovulation after menses, nine of the thirteen (69 percent) had ended full breastfeeding (0.75–9.0 months 
prior). Of the four women who ovulated prior to six months, two of these women ovulated before their 
first menses (and had four- and six-day luteal phases), and two ovulated after their first menses (both 
had five-day luteal phases). In these ovulations prior to six months, three of four women ended full 
breastfeeding one, two, and three weeks prior, and the fourth woman ended full breastfeeding two 
months after first ovulation. 
In the five women (22 percent) who ovulated while still fully breastfeeding (in two women 
ovulation occurred seven weeks before the end of full breastfeeding—see Figure 4, in two women two 
weeks before, and in one woman one week before), their luteal phases were only three to five days 
long. These women were part of the category of women who ovulate early as described qualitatively 
below and shown in Figure 4. 
As shown in the last column of Table 2, the five women who had ovulation after ending full 
breastfeeding did not fully breastfeed for very long (2.5–4.5 months) and completely weaned earlier 
than the overall group (6.3 vs. 16.1 months). 
Time to Fertility 
Return to fertility could be identified by pregnancies that occurred in three of the twenty-six 
women, at six (still fully breastfeeding), twelve, and eighteen months postpartum (both completely 
weaned from breastfeeding). Among the other women, none of their cycles met criteria for fertility as 
described in Table 1. Of the remaining eighteen women who had transition cycles to be analyzed, 
fourteen of them had fertile range PDG levels (>13.5 µmol/24 h) in their transition cycles, but none of 
these had luteal phase lengths that were adequate (range: two to ten days). 
Qualitative Description of the Postpartum Transition 
After visually inspecting each woman’s postpartum transition, the patterns were divided into 
three broad categories (Table 3): ovarian quiescence with delayed ovulation (Figure 2, N = 11 or 42 
percent), follicular activity with delayed ovulation (Figure 3, N = 4 or 15 percent), and relatively early 
ovulation (Figure 4, N = 11 or 42 percent). 
Table 3. Qualitative Categories of Postpartum Transitions in the Twenty-Six Participants. 
Category Number and Proportion of Women 
Ovarian quiescence with delayed ovulation (Figure 2) 11 (42.3 percent) 
Follicular activity with delayed ovulation (Figure 3) 4 (15.4 percent) 
Early ovulation (Figure 4) 11 (42.3 percent) 
 
 
Figure 2. Representative hormone, mucus, and menses profile of a woman with prolonged ovarian quiescence and 
delayed ovulation (green, yellow, blue as described in Figure 1, red represents menses). Two arrows represent the 
end of full breastfeeding with the introduction of formula or solids (4.5 months) and complete weaning (11 
months). The fact that full weaning occurred 6.5 months after the introduction of supplements indicates that the 
latter was very gradual and that breastfeeding was maintained at a rather intense level. This is recognized as a 
factor of delay in the return to fertility. The dotted line is the PDG threshold of 9 µmol/24 h as the biochemical 
criterion of ovulation. PDG = pregnanediol glucuronide. 
 
Figure 3. Representative hormone, mucus, and menses profile of a woman with follicular activity and delayed 
ovulation (green, yellow, blue as described in Figure 1, red represents menses). Two arrows represent the end of 
full breastfeeding with the introduction of formula or solids (3.0 months) and complete weaning (4.1 months). The 
short time span between the two landmarks indicates that breastfeeding intensity decreased rapidly, thereby 
probably stimulating reactivation of the hypothalamic–pituitary–ovarian axis. The dotted line is the PDG threshold 
of 9 µmol/24 h as the biochemical criterion of ovulation. PDG = pregnanediol glucuronide. 
 
 
Figure 4. Representative hormone, mucus, and temperature profile of a woman with relatively early ovulationprior 
to the end of full breastfeeding (green, yellow, blue as described in Figure 1, red represents menses). Two arrows 
represent the end of full breastfeeding with the introduction of formula or solids (5.0 months) and complete 
weaning (5.7 months). The dotted line is the PDG threshold of 9 µmol/24 h as the biochemical criterion for 
ovulation. 
 
Although the sample sizes were not large enough for statistical power to compare these three 
groups, it is interesting to note that first menses occurred on average at 7.5, 7.5, and 6.5 months in the 
three categories, respectively (ovarian quiescence, follicular activity and delayed ovulation, and early 
ovulation). First ovulation occurred on average at 9.0 months for those with ovarian quiescence, at 8.8 
months for those with follicular activity and delayed ovulation, and at 7.9 months for those with early 
ovulation (approximately one month earlier). All of the women who ovulated before weaning from full 
breastfeeding were in the early ovulation category. Also, as can be seen in Table 2, the earlier that 
menses and ovulation occurred, menses usually occurred before ovulation. 
Correlation between Mucus and Total Estrogen (Follicular Activity) 
During amenorrhea and before first ovulation, the daily mucus observations were compared 
with underlying hormone activity; it was found that 53.6 percent of the total daily mucus observations 
overestimated the underlying hormone changes, 39.1 percent corresponded to the underlying hormone 
changes, and 7.3 percent underestimated the underlying hormone changes. 
Correlation between Mucus and Progesterone (Postovulation) 
In the transition cycles after first menses, cycles were analyzed for mucus changes reflecting the 
postovulatory progesterone rise; it was found that thirty-three of seventy-eight cycles (42 percent) had 
typical mucus changes expected (where mucus changes from peak mucus to the basic infertile pattern), 
and forty-five of seventy-eight cycles (58 percent) did not have these mucus changes with the 
progesterone rise. Another three cycles did not have enough data to analyze. 
Discussion 
Findings 
Time to first menses and first ovulation were similar to other studies in postpartum women 
(Taylor et al. 2003; Wei and Qiu 2007) at 7.0 and 8.0 months, respectively, and representing the usual 
introduction of solids and end of full breastfeeding which leads to the removal of the inhibitory 
mechanism of ovulation. Taylor et al. (2003) found that trained, breastfeeding women had a median 
return of fertility (i.e., first menses) at 12.75 months versus untrained breastfeeding women at four 
months. In another study, Li and Qui (2007)discovered among 101 breastfeeding mothers, 52.5 percent 
had a resumption of ovulation on average within 5.1 months after delivery. However, there was a lot of 
variability in the Li and Qui study due to total versus partial breastfeeding and the initiation of 
supplements. 
We recognized three broad categories of urinary hormonal profiles for the return of fertility 
postpartum: (1) ovarian quiescence and delayed ovulation (low TE and PDG excretion rates for many 
months as in Figure 2), (2) follicular activity without luteinization and delayed ovulation (initial constant 
low TE and PDG excretion rates followed by cyclical rises and falls in the TE excretion rates but little 
response from the PDG excretion rates as shown in Figure 3), and (3) relatively early ovulation (cyclical 
changes in both TE and PDG excretion rates with the absolute values of the PDG excretion rates 
increasing to exceed 9 µmol/24 h). Of interest, women who ovulated (with normal PDG profiles) during 
full breastfeeding were in the category of women with early ovulation, and it is possible that these 
women represent a group of women whose hypothalamic–pituitary–ovarian axis is less impacted by the 
inhibitory effect of suckling and/or prolactin on ovulation. Women with a history of early ovulation (and 
perhaps early unintended pregnancy in the postpartum period) should be more cautious in future 
postpartum periods regarding the possibility of early ovulation. 
As discussed in the Kennedy et al. (1995) paper using the same data, mucus changes were found 
to overestimate hormone changes over half the time during amenorrhea, which means that the mucus 
was not always related to the underlying TE excretion rates. This leads to more required abstinence 
during the postpartum period since if it is believed that the mucus is reflecting the underlying 
physiological events fertility has to be assumed (albeit incorrectly in these cases). In addition, when the 
mucus scores underestimated the urinary hormone measurements (on 7.3 percent of days during 
amenorrhea), this means that despite underlying potential fertility the mucus symptom is not reflecting 
it and infertility may be assumed incorrectly. Comparing our findings to Brown, Harrison, and Smith’s 
data from 1985 in a separate study but using similar urinary hormone measurements, they found that 
21 percent (seven of thirty-three) had mucus scores that overestimated hormone values indicating 
fertility when there was none, 21 percent (seven of thirty-three) had mucus that underestimated 
hormone values indicating infertility when fertility was actually present, and 58 percent (nineteen of 
thirty-three) had mucus scores that reflected ovarian activity. Our findings were less positive, showing 
54 percent had mucus scores that overestimated hormone values, 7 percent had mucus scores that 
underestimated hormone values, and only 39 percent had mucus scores that reflected correctly the 
underlying ovarian activity. 
In the transition cycles, couples using a mucus-only approach would be waiting for mucus to dry 
up or return to a basic infertile pattern to indicate the beginning of the luteal infertile phase. 
Unfortunately, this occurred in only 42 percent of transition cycles postpartum. This would lead to 
extended periods of abstinence, just like the overestimate of estrogen changes in the amenorrheic 
period. The overestimation of fertility with cervical mucus observation and ratings would make a 
postpartum NFP method more conservative and result in very low correct use unintended pregnancies. 
However, the extended abstinence may also lead couples to knowingly taking a chance with intercourse 
on estimated fertile days, potentially increasing total unintended pregnancies. This phenomenon is 
exhibited in the high pregnancy rates in postpartum NFP studies. 
Limitations 
The most significant limitation of this study is its small sample size. Unfortunately, it has not 
been possible to retrieve and analyze demographic and cycle data for the Sydney and Birmingham 
participants. 
The intention in the present study was to follow-up this older data set with an evaluation of a 
current population of postpartum women with a urinary hormone measurement device, but up to this 
point we have not had enough urinary hormone monitors to measure E1G and PDG together in a pilot 
group of postpartum women. Thus, the ability to replicate the data in a new population is another 
limitation that we did not foresee. 
Implications and Future Directions 
Future studies examining the trends in hormone patterns using estrogen (with current devices 
this would be estrone-3-glucuronide rather than total estrogens as was done in this study), LH, and PDG 
in the postpartum period with larger numbers of participants would be useful. 
At present, the Marquette Method Postpartum Protocol is the most robust method of 
identifying the return of fertility postpartum, and its efficacy for avoiding pregnancy has previously been 
demonstrated in two studies (Bouchard, Schneider, and Fehring 2013; Fehring, Schneider, and Bouchard 
2017). A study is underway to evaluate the parameters of the return of fertility in a population of 
women who are presently using the Marquette Method Postpartum Protocol. The addition of urinary 
PDG measurement could assist in determining whether a rise in LH (as shown by the Clearblue Fertility 
Monitor used in the Marquette Method Postpartum Protocol) was actually ovulatory. A lower-cost 
protocol might include the combination of mucus rating with use of LH test strips to help clarify whether 
peak mucus is potentially ovulatory (Leiva et al. 2014), and this could be combined with subsequent 
measurements of PDG (Blackwell et al. 2016) to guide a woman through her postpartum fertility. 
Conclusions 
Recognizing specific patterns of ovarian activity in postpartum women is helpful in the future 
development of postpartum protocols for NFP. Using a home-based urinary PDG measurement would 
provide further detail to confirm when ovulation occurs, giving a more precise definition for the luteal 
infertile phase for women seeking to avoid pregnancy postpartum. 
Appendix A 
Brown Ovarian Monitor Guidelines 
Monitor use during breastfeeding 
Establish E1G baseline 
This is done by testing daily, consecutive urine samples for E1G over seven days. Notify your 
contact person of the results who will then establish your baseline level. 
Zero to six months postpartum 
Check E1G level twice a week. If below the baseline, you are in an infertile phase. If the E1G 
level is above the baseline or there is a change in your Basic Infertile Pattern (BIP)—Billings Ovulation 
Method (BOM), continue to do daily E1G tests. Notify your contact person who will advise you of further 
testing. If you have a previous history of returning to fertility earlier than six months then E1G should be 
checked twice a week for zero to two months increasing to three times a week after that. 
Six to nine months postpartum 
Check E1G level every third day. If at or below your baseline, you are in an infertile phase. If the 
E1G level is above the baseline or there is a change in your BIP, continue daily E1G tests. Notify your 
contact person who will advise you of further testing. 
Nine months to weaning 
Check E1G level every second day. If at or below your baseline, you are in an infertile phase. If 
the E1G level is above the baseline or there is a change in your BIP, continue daily E1G tests. Notify your 
contact person who will advise you of further testing. 
Interpreting the results 
Days of infertility: 1. E1G values at or below the baseline and 2. Pregnanediol glucuronide (PDG) 
values above the ΔT cutoff. 
Days of fertility: All days with raised E1G values above your baseline (associated with low PDG 
values). 
A rise in E1G above the baseline indicates the beginning of the fertile phase. The E1G values 
continue to rise for three to seven days to reach a peak. They then fall abruptly. On the day of the fall, 
PDG measurements should be commenced. The PDG value on the day of the E1G fall will be low, but it 
will continue to rise and on the third day be approaching or will have passed the PdG “ΔT cutoff.” Once 
the ΔTcutoff has been reached, ovulation has already occurred, and the fertile phase has ended. No 
further testing is required for the remainder of the cycle. 
The E1G level may go above the baseline for one day only with no change in the BIP. While the 
day of raised E1G level is unavailable for intercourse, the following day with a baseline E1G level and 
continued BIP (BOM) indicates a return to the infertile phase. 
If the E1G level remains above the baseline for two or more days, look for the E1G fall and 
commence PDG measurements on this day. If the PDG value rises to the ΔT cutoff, ovulation has 
occurred, and the late infertile days have commenced. However, if the PDG value remains low two to 
three days after the E1G fall, recommence or continue testing the E1G levels. If the E1G value returns to 
baseline and remains at baseline for three days with an associated low PDG level, then you have 
returned to infertile phase. Intercourse can be resumed applying the E1G baseline in conjunction with 
the BIP. 
When monitoring ovarian activity, do not expect stereotyped patterns and do not ignore the 
hormone values no matter what you expect; they are very unlikely to be wrong. 
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